We wanted to shine a spotlight on this incredible venture by the premier company in microgravity research and an essential partner of the ISS, Space Tango. From their website:
Space Tango, a leader in the commercialization of space through R&D, bioengineering and manufacturing in microgravity, today announced ST-42, a fully autonomous robotic orbital platform designed specifically for scalable manufacturing in space. Launching in the mid 2020’s, ST-42 aims to harness the unique environment of microgravity to produce high value products across industries; from patient therapeutics to advanced technology products that have the potential to revolutionize industries here on Earth. ST-42 is an extension of the International Space Station’s (ISS) capabilities, and NASA’s creation of a robust commercial marketplace in low Earth orbit (LEO).
Space Tango looks to provide an orbital manufacturing space capable of materials manufacturing and of complying with the FDA’s strict regulations so that commercial developers can conduct pioneering biotech and pharmaceutical research.